Gennova’s GEMCOVAC-OM Omicron-specific mRNA-based booster vaccine gets EUA in India
The Department of Biotechnology (DBT), part of the Indian Ministry of Science & Technology, has revealed that the Omicron-specific mRNA-based booster vaccine, developed by Pune-based Gennova Biopharmaceuticals, has received Emergency Use Authorization (EUA) from the Drug Control General of India (DCGI). This significant development has been facilitated through the Mission COVID Suraksha initiative, managed by […]